4//SEC Filing
Fischel Nathan 4
Accession 0001289340-18-000041
CIK 0001289340other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:01 PM ET
Size
13.1 KB
Accession
0001289340-18-000041
Insider Transaction Report
Form 4
Fischel Nathan
Director10% Owner
Transactions
- Award
Common Stock Warrant (right to buy)
2018-03-01+12,307,692→ 12,307,692 total(indirect: See footnote 1)Exercise: $0.28From: 2016-09-29Exp: 2021-09-29→ Common Stock (12,307,692 underlying) - Exercise of In-Money
Common Stock
2018-03-05$0.28/sh+12,307,692$3,446,154→ 13,680,554 total(indirect: See footnote 1) - Disposition to Issuer
Common Stock Warrant (right to buy)
2018-03-01−12,307,692→ 0 total(indirect: See footnote 1)Exercise: $0.70From: 2016-09-29Exp: 2021-09-29→ Common Stock (12,307,692 underlying) - Exercise of In-Money
Common Stock Warrant (right to buy)
2018-03-05−12,307,692→ 0 total(indirect: See footnote 1)Exercise: $0.28From: 2016-09-29Exp: 2021-09-29→ Common Stock (12,307,692 underlying)
Holdings
- 74,500
Common Stock
Footnotes (3)
- [F1]Held by funds of which DAFNA Capital Management, LLC, a Delaware limited liability company, is the investment manager and general partner. Dr. Fischel is the Chief Executive Officer, of DAFNA Capital Management, LLC.
- [F2]On February 28, 2018, the issuer and certain holders of outstanding warrants issued pursuant to the Stock Purchase Agreement dated September 26, 2016, including the reporting person, entered into an amendment to the warrants. The amendment provided that the exercise price of the warrants would be reduced for a limited period of time, provided that at least $6 million of warrants was exercised during the limited period. This condition was satisfied on March 1, 2018.
- [F3]The transactions reported in the first two lines of Table II above report the amendment of the warrant to temporarily reduce the exercise price from $0.70 per share to $0.28 per share. The amendment is reported as the disposition of the old warrant and the acquisition of a new one. The amendment to the warrant was approved by a transaction committee consisting solely of independent directors for purposes of Rules 16b-3(d) and (e).
Documents
Issuer
Stereotaxis, Inc.
CIK 0001289340
Entity typeother
Related Parties
1- filerCIK 0001389932
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:01 PM ET
- Size
- 13.1 KB